Ca2+ Binding to the First Epidermal Growth Factor-like Domain of Human Blood Coagulation Factor IX Promotes Enzyme Activity and Factor VIII Light Chain Binding
Open Access
- 1 October 1996
- journal article
- Published by Elsevier
- Vol. 271 (41) , 25332-25337
- https://doi.org/10.1074/jbc.271.41.25332
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Sequence Glu1811-Lys1818 of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IXPublished by Elsevier ,1996
- The structure of a Ca2+-binding epidermal growth factor-like domain: Its role in protein-protein interactionsCell, 1995
- The Role of Cleavage of the Light Chain at Positions Arg1689 or Arg1721 in Subunit Interaction and Activation of Human Blood Coagulation Factor VIIIPublished by Elsevier ,1995
- Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q)Biochemistry, 1994
- Protein engineering of the hydrophobic domain of human factor IXProtein Engineering, Design and Selection, 1994
- Four Novel FBN1 Mutations: Significance for Mutant Transcript Level and EGF-like Domain Calcium Binding in the Pathogenesis of Marfan SyndromeGenomics, 1993
- A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like moduleHuman Molecular Genetics, 1993
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- The molecular basis of blood coagulationCell, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976